Adherence to healthy dietary patterns, including anti-inflammatory and Mediterranean diets, is associated with a lower risk of developing rheumatoid arthritis (RA), according to study findings ...

Oral presentation name: Enobosarm in Combination With GLP-1RA is Selective for Fat Loss While Preserving Lean and Function ...

Electra Therapeutics has garnered the funds it needs to complete a pivotal trial of its lead drug, angling to become the ...

A study presented at ACR Convergence 2025 has sparked interest among doctors and patients alike. Drugs originally made for ...

A daily pill to help people newly diagnosed with type 1 diabetes, or those at risk of developing it, live without the ...

Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...

A HIGH-VALUE individual (HVI) alias Alvin, 34, was arrested during a buy-bust operation executed by the Iloilo City Police ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents — and many more are considering following suit. States cannot ...

GLP-1RA use was associated with a lower incidence of rheumatic diseases such as rheumatoid arthritis, gout, and ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

AnaptysBio (ANAB) announced late-breaking data from the robust, global 424-patient Phase 2b trial of rosnilimab, a selective and potent pathogenic ...